Francesca Gatti
Senior Scientist at Alv B AS- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Alv B AS
-
Norway
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Scientist
-
Dec 2021 - Present
-
-
-
GIAMAG Technologies
-
Norway
-
Biotechnology
-
Project Manager
-
Jun 2019 - Nov 2021
-
-
-
K. G. Jebsen Inflammation Research Centre, University of Oslo
-
Oslo Area, Norway
-
Postdoc
-
Apr 2014 - May 2018
Study of pathogenic mechanisms that trigger the development of chronic inflammation and fibrosis Study of pathogenic mechanisms that trigger the development of chronic inflammation and fibrosis
-
-
-
University of Oslo (UiO)
-
Norway
-
Education Administration Programs
-
700 & Above Employee
-
PhD Student
-
Feb 2011 - Feb 2014
Development of a new protocol for islet encapsulation in an immuno-functionalized hydrogel for islet graft immunoprotection in order to reduce the immunosuppressive regimen in islet cell transplantation. Development of a new protocol for islet encapsulation in an immuno-functionalized hydrogel for islet graft immunoprotection in order to reduce the immunosuppressive regimen in islet cell transplantation.
-
-
-
Boston Children's Hospital - Harvard Medical School
-
Boston, Massachusetts, United States
-
Research Fellow
-
Apr 2011 - Aug 2012
Investigated the role of TIM4, a novel costimulatory molecule, in murine models of anti-islets allo- and autoimmunity Investigated the role of TIM4, a novel costimulatory molecule, in murine models of anti-islets allo- and autoimmunity
-
-
-
University of Illinois Chicago
-
United States
-
Higher Education
-
700 & Above Employee
-
Research Specialist
-
Oct 2008 - Feb 2011
Member of the "Islet Cell Isolation Team", responsible for manufacturing human islet cells, as part of "UIC Islet Cell Transplantation Program", a NIH-funded phase III clinical trial for FDA approval of islet transplantation as cell therapy for autoimmune diabetes. Involved in two main research projects aiming at increasing islet cell mass prior to transplantation and reducing the use of immunosuppressive drugs following islet transplantation, as part of "The Chicago Diabetes Project", an international collaboration of interdisciplinary scientists. Show less
-
-
Education
-
Università del Salento
Doctor of Philosophy (Ph.D.), Biology and Biotechnology -
Università degli Studi di Roma Tre
Master's Degree, Molecular Biology